Dermatological adverse effects during genotype-1 hepatitis C treatment with the protease inhibitors telaprevir and boceprevir. Patient management-Reference-Cited by-同舟云学术

Dermatological adverse effects during genotype-1 hepatitis C treatment with the protease inhibitors telaprevir and boceprevir. Patient management

Published:2012-10 Issue:5 Volume:36 Page:437-440
ISSN:2210-7401
Container-title:Clinics and Research in Hepatology and Gastroenterology
language:en
Short-container-title:Clinics and Research in Hepatology and Gastroenterology

Author:

Picard Odile,Cacoub Patrice

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference16 articles.

1. Dermatological disorders associated with chronic hepatitis C: effect of interferon therapy;Berk;Clin Gastroenterol and Hepatol,2007

2. Extrahepatic manifestations of hepatitis C infection;Mayo;Am J med Sci,2003

3. Hepatitis C virus-related skin disease;Doutre;Arch dermatol,1999

4. Manifestations cutanées au cours des traitements par interferon;Descamps;Presse Med,2005

5. Cutaneous necrosis complicating the injection of pegylated interferon alpha -2b in a patient with chronic hepatitis C;Rosina;Acta Dermatovenerol Croat,2008

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A rare and severe cutaneous adverse effect of telaprevir: drug rash with eosinophilia and systemic symptoms;Giornale Italiano di Dermatologia e Venereologia;2019-06

2. Adverse effects of direct acting antiviral-based regimens in chronic hepatitis C patients: a Brazilian experience;INT J CLIN PHARM-NET;2017

3. Cutaneous Eruption due to Telaprevir;Case Reports in Dermatology;2015-09-29

4. Telaprevir may induce adverse cutaneous reactions by a T cell immune-mediated mechanism;Annals of Hepatology;2015-05

5. Toxicodermias por telaprevir en el tratamiento de la infección crónica por el genotipo 1 del virus de la hepatitis C. Estudio prospectivo;Actas Dermo-Sifiliográficas;2015-04